Evidence map›Paper›PMID 22617684›Full record

ArticleExperimental & molecular medicine2012

B cell-associated immune profiles in patients with end-stage renal disease (ESRD).

Kyoung Woon Kim, Byung Ha Chung, Eun Joo Jeon, Bo-Mi Kim, Bum Soon Choi, Cheol Whee Park, Yong-Soo Kim, Seok-Goo Cho, Mi-La Cho, Chul Woo Yang

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Dynamic assessment of interleukin-6 during hemodialysis and mortality in coronavirus disease-19.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2021
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kyoung Woon KimConversant Research Consortium in Immunologic Disease,Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-040, Korea.
Byung Ha Chung
Eun Joo Jeon
Bo-Mi Kim
Bum Soon Choi
Cheol Whee Park
Yong-Soo Kim
Seok-Goo Cho
Mi-La Cho
Chul Woo Yang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the previous studies on immune dysregulation in end-stage renal disease (ESRD) have focused on T cell immunity. We investigated B cell subpopulations in ESRD patients and the effect of hemodialysis (HD) on B cell-associated immune profiles in these patients. Forty-four ESRD [maintenance HD patients (n = 27) and pre-dialysis patients (n = 17)] and 27 healthy volunteers were included in this study. We determined the percentage of B cell subtypes, such as mature and immature B cells, memory B cells, and interleukin (IL)-10+ cells, as well as B cell-producing cytokines (IL-10, IL-4 and IL-21) by florescent activated cell sorting (FACS). B cell-associated gene expression was examined using real-time PCR and B cell producing cytokines (IL-10, IL-4 and IL-21) were determined using an enzyme- linked immunosorbent assay (ELISA). The percentage of total B cells and mature B cells did not differ significantly among the three groups. The percentages of memory B cells were significantly higher in the pre-dialysis group than in the HD group (P < 0.01), but the percentage of immature B cells was significantly lower in the pre-dialysis group than in the other groups. The percentages of IL-10-expressing cells that were CD19+ or immature B cells did not differ significantly (P > 0.05) between the two subgroups within the ESRD group, but the serum IL-10 concentration was significantly lower in the pre-dialysis group (P < 0.01). The results of this study demonstrate significantly altered B cell-associated immunity. Specifically, an imbalance of immature and memory B cells in ESRD patients was observed, with this finding predominating in pre-dialysis patients.

Indexed as

Adaptor Proteins, Signal TransducingAdultAntigens, CD19B-LymphocytesB-Lymphocyte SubsetsCytokinesFemaleHumansImmunophenotypingInterleukin-10Kidney Failure, ChronicLeukocytes, MononuclearMaleMiddle AgedProto-Oncogene ProteinsT-Lymphocytes, RegulatoryAdaptor Proteins, Signal TransducingAntigens, CD19B cell linker proteinCytokinesInterleukin-10Proto-Oncogene ProteinsTCL1A protein, human

Identifiers

PMID22617684
PMCPMC3429810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.